{
  "ptid_time": "137_S_0481_2006-05-11",
  "img_path": "/data/qiuhui/data/adni/images/137_S_0481/2006-05-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 48,762 mm³, 3.7% above the reference mean. With a Z-score of 0.11 (54.3th percentile), this represents normal volume ; hippocampal volume measures 6,102 mm³, 12.4% below the reference mean. With a Z-score of -1.07 (14.1th percentile), this represents mild atrophy; whole brain volume measures 977,698 mm³, 5.0% below the reference mean. With a Z-score of -0.66 (25.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,705 mm³, 6.7% below the reference mean. With a Z-score of -0.44 (33.2th percentile), this represents normal volume ; fusiform gyrus volume measures 17,772 mm³, 1.6% below the reference mean. With a Z-score of -0.14 (44.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,695 mm³, 7.3% below the reference mean. With a Z-score of -0.66 (25.6th percentile), this represents normal volume . ",
  "text_data": "Age is 84.8 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Smoking; Malignancy; Major Surgical Procedures. MMSE: 24.0. Logical Memory: 6.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 594.00 pg/mL (mild reduced); Total tau: 340.40 pg/mL (mild elevated); Phosphorylated tau: 35.95 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows mild atrophy (Z-score -1.07, 14.1th percentile), which is notable given the patient's age (84.8) and APOE4 carrier status. The MMSE score of 24 suggests mild cognitive impairment, and the biomarker profile (mildly reduced Aβ, mildly elevated T-tau, and moderately elevated P-tau) supports underlying Alzheimer's pathology. Other brain volumes are within normal ranges.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's disease)  \n**Confidence:** **Medium** (due to the presence of hippocampal atrophy and biomarker abnormalities, but lack of severe global atrophy or advanced cognitive decline)",
  "timestamp": "2025-07-26T16:11:25.642756"
}